<p>Weighted differences (with 95% CI) of mean serum [Na<sup>+</sup>] in dead and alive patients.</p
<p>Comparison of mortality, body weight (BW) and heart weight/body weight (HW/BW) among experimental...
<p>*<i>p</i><0.05 <i>vs</i> Sham operation group;</p><p>**<i>p</i><0.05 <i>vs</i> I/R group.</p><p>S...
<p>SD: Standard deviation. #PC patient samples were limited to treatment naïve samples only for this...
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo or active control in...
<p>Comparison of clinical manifestations between deceased and control PM/DM patients [x ± SD or n (%...
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo in Caucasian.</p
<p>Comparison of ADC parameters between patients who died of cancer and those who were alive at the ...
<p>Comparison of baseline characteristics of deceased and surviving patients in general medical ward...
The SMD reflects the difference in the average biomarker level in patients who died compared to thos...
<p>Odds ratio for overall mortality rate in patients from studies in which a threshold for serum [Na...
Biomarkers are sorted by SMD magnitude and included if they are statistically significant and repres...
Comparison of blood parameters between patients’ subgroups and healthy individuals.</p
<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo or active control in ...
<p>Note: Mean difference reflects the mean difference between cases and controls divided by the its ...
<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo in Caucasian.</p
<p>Comparison of mortality, body weight (BW) and heart weight/body weight (HW/BW) among experimental...
<p>*<i>p</i><0.05 <i>vs</i> Sham operation group;</p><p>**<i>p</i><0.05 <i>vs</i> I/R group.</p><p>S...
<p>SD: Standard deviation. #PC patient samples were limited to treatment naïve samples only for this...
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo or active control in...
<p>Comparison of clinical manifestations between deceased and control PM/DM patients [x ± SD or n (%...
<p>Weighted mean difference in change in HbA1c for AGI treatment versus placebo in Caucasian.</p
<p>Comparison of ADC parameters between patients who died of cancer and those who were alive at the ...
<p>Comparison of baseline characteristics of deceased and surviving patients in general medical ward...
The SMD reflects the difference in the average biomarker level in patients who died compared to thos...
<p>Odds ratio for overall mortality rate in patients from studies in which a threshold for serum [Na...
Biomarkers are sorted by SMD magnitude and included if they are statistically significant and repres...
Comparison of blood parameters between patients’ subgroups and healthy individuals.</p
<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo or active control in ...
<p>Note: Mean difference reflects the mean difference between cases and controls divided by the its ...
<p>Weighted mean difference in changes in FPG for AGI treatment versus placebo in Caucasian.</p
<p>Comparison of mortality, body weight (BW) and heart weight/body weight (HW/BW) among experimental...
<p>*<i>p</i><0.05 <i>vs</i> Sham operation group;</p><p>**<i>p</i><0.05 <i>vs</i> I/R group.</p><p>S...
<p>SD: Standard deviation. #PC patient samples were limited to treatment naïve samples only for this...
DOI
Add to ORKG